NDC 0069-0305

Trazimera-qyyp

Trastuzumab

Trazimera-qyyp is a Kit in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is .

Product ID0069-0305_0f98e9ea-ef07-48eb-a8f4-57aa15967d9c
NDC0069-0305
Product TypeHuman Prescription Drug
Proprietary NameTrazimera-qyyp
Generic NameTrastuzumab
Dosage FormKit
Marketing Start Date2020-02-24
Marketing CategoryBLA / BLA
Application NumberBLA761081
Labeler NamePfizer Laboratories Div Pfizer Inc
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0069-0305-01

1 KIT in 1 KIT (0069-0305-01) * 20 mL in 1 VIAL, MULTI-DOSE (0069-0306-01) * 20 mL in 1 VIAL (0069-0307-01)
Marketing Start Date2020-02-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0069-0305-01 [00069030501]

Trazimera-qyyp KIT
Marketing CategoryBLA
Application NumberBLA761081
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-02-24

Drug Details

NDC Crossover Matching brand name "Trazimera-qyyp" or generic name "Trastuzumab"

NDCBrand NameGeneric Name
0069-0305Trazimera-qyyptrastuzumab
50242-132HerceptinTrastuzumab
50242-134HerceptinTrastuzumab
50242-333HerceptinTrastuzumab
63459-303HERZUMATRASTUZUMAB
63459-305HERZUMATRASTUZUMAB
67457-845OGIVRItrastuzumab
67457-847OGIVRItrastuzumab
67457-991OGIVRItrastuzumab
0006-5033Ontruzanttrastuzumab
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.